Search

everythinglearnresearchcommunity

for

Search:↓

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Infliximab may cause hair loss in Crohn's disease patients.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Montelukast is linked to increased risks of suicidal thoughts and depression.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

EE/CMA is more effective than EE/LNG in reducing acne.

JAK inhibitors are effective treatments for alopecia areata.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.